Resistance of interleukin-6 to the extracellular inhibitory
environment promotes axonal regeneration and
functional recovery following spinal cord injury

Yang,Gang; Tang,Wen-Yuan

doi:10.3892/ijmm.2017.2848

Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury

Authors:
- Gang Yang
- Wen-Yuan Tang
View Affiliations

Affiliations: Department of Neurosurgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China
Published online on: January 5, 2017 https://doi.org/10.3892/ijmm.2017.2848
Pages: 437-445

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Interleukin-6 (IL)-6 was originally discovered as a factor that contributes to the secondary pathological and inflammatory response in the central nervous system (CNS) following injury. However, accumulating evidence suggests that IL-6 is also involved in functional and structural recovery following CNS injury by promoting axonal sprouting. This suggests a potential dual role of IL-6 in CNS injury. However, the definitive function of IL-6 in neural injury and the corresponding underlying mechanisms are still topics of controversy. The present study was carried out to examine the potential function of IL-6 in resistance to neurite growth‑inhibitory effects via regulation of the expression of growth associated protein-43 (GAP-43), myelin-associated neurite outgrowth inhibitor (Nogo-A) and its receptor (NgR). Rat dorsal root ganglion (DRG) neurons cultured in an inhibitory microenvironment mimicking injured CNS were used to investigate the effects of IL-6 on the outgrowth of neuronal processes. Additionally, IL-6 was subarachnoidally injected into rats to establish a spinal cord injury (SCI) model, and the neurobehavioral manifestations and neural morphology were subsequently evaluated to determine the effect of IL-6 on neural regeneration. Finally, the potential molecular mechanisms of IL-6-mediated regeneration and functional recovery following CNS injury are discussed. The results of the present study demonstrated that the in vitro administration of IL-6 enhanced the neurite outgrowth of DRG neurons in a dose-dependent manner via resisting the inhibitory function of myelin proteins. All doses of the IL-6 subarachnoid injection improved the Basso, Beattie and Bresnahan scores following SCI, with a large number of axonal sproutings observed at the spinal lesion site, and several sprouting fibers being elongated and bypassing the lesion and entered the caudal spinal cord. Additionally, a significantly increased density area of diaminobenzidine-labeled neural fiber was observed in rats that received a subarachnoid injection of IL-6, and the rats exhibited increased expression of GAP-43 and decreased expression of Nogo-A. In conclusion, the results of the present study indicated that IL-6 interferes with the inhibitory functions of myelin proteins by upregulating the expression of GAP-43 and simultaneously downregulating the expression of Nogo-A and NgR to promote axonal sprouting and functional recovery following SCI.

View Figures

View References

1	Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL and He Z: Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 417:941–944. 2002. View Article : Google Scholar : PubMed/NCBI
2	Filbin MT: Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci. 4:703–713. 2003. View Article : Google Scholar : PubMed/NCBI
3	Geoffroy CG and Zheng B: Myelin-associated inhibitors in axonal growth after CNS injury. Curr Opin Neurobiol. 27:31–38. 2014. View Article : Google Scholar : PubMed/NCBI
4	Lee JK and Zheng B: Role of myelin-associated inhibitors in axonal repair after spinal cord injury. Exp Neurol. 235:33–42. 2012. View Article : Google Scholar
5	Leibinger M, Andreadaki A, Diekmann H and Fischer D: Neuronal STAT3 activation is essential for CNTF- and inflammatory stimulation-induced CNS axon regeneration. Cell Death Dis. 4:e8052013. View Article : Google Scholar : PubMed/NCBI
6	Hakkoum D, Stoppini L and Muller D: Interleukin-6 promotes sprouting and functional recovery in lesioned organotypic hippocampal slice cultures. J Neurochem. 100:747–757. 2007. View Article : Google Scholar
7	Chidlow G, Wood JP, Ebneter A and Casson RJ: Interleukin-6 is an efficacious marker of axonal transport disruption during experimental glaucoma and stimulates neuritogenesis in cultured retinal ganglion cells. Neurobiol Dis. 48:568–581. 2012. View Article : Google Scholar : PubMed/NCBI
8	Wang T, Xiong JQ, Ren XB and Sun W: The role of Nogo-A in neuroregeneration: a review. Brain Res Bull. 87:499–503. 2012. View Article : Google Scholar : PubMed/NCBI
9	Pernet V and Schwab ME: The role of Nogo-A in axonal plasticity, regrowth and repair. Cell Tissue Res. 349:97–104. 2012. View Article : Google Scholar : PubMed/NCBI
10	Yu CH, Yhee JY, Kim JH, Im KS, Kim NH, Jung DI, Lee HC, Chon SK and Sur JH: Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury. J Vet Sci. 12:299–301. 2011. View Article : Google Scholar : PubMed/NCBI
11	Okada S, Nakamura M, Mikami Y, Shimazaki T, Mihara M, Ohsugi Y, Iwamoto Y, Yoshizaki K, Kishimoto T, Toyama Y, et al: Blockade of interleukin-6 receptor suppresses reactive astrogliosis and ameliorates functional recovery in experimental spinal cord injury. J Neurosci Res. 76:265–276. 2004. View Article : Google Scholar : PubMed/NCBI
12	Guerrero AR, Uchida K, Nakajima H, Watanabe S, Nakamura M, Johnson WE and Baba H: Blockade of interleukin-6 signaling inhibits the classic pathway and promotes an alternative pathway of macrophage activation after spinal cord injury in mice. J Neuroinflammation. 9:402012. View Article : Google Scholar : PubMed/NCBI
13	Wang XQ, Peng YP, Lu JH, Cao BB and Qiu YH: Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci Lett. 450:122–126. 2009. View Article : Google Scholar
14	Ou S, Zhao YD, Xiao Z, Wen HZ, Cui J and Ruan HZ: Effect of lappaconitine on neuropathic pain mediated by P2X₃ receptor in rat dorsal root ganglion. Neurochem Int. 58:564–573. 2011. View Article : Google Scholar : PubMed/NCBI
15	Basso DM, Beattie MS and Bresnahan JC: A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma. 12:1–21. 1995. View Article : Google Scholar : PubMed/NCBI
16	Bareyre FM, Haudenschild B and Schwab ME: Long-lasting sprouting and gene expression changes induced by the monoclonal antibody IN-1 in the adult spinal cord. J Neurosci. 22:7097–7110. 2002.PubMed/NCBI
17	Matsushita H, Endo S, Kobayashi E, Sakamoto Y, Kobayashi K, Kitaguchi K, Kuroki K, Söderhäll A, Maenaka K, Nakamura A, et al: Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells. J Biol Chem. 286:25739–25747. 2011. View Article : Google Scholar : PubMed/NCBI
18	Cao Z, Gao Y, Bryson JB, Hou J, Chaudhry N, Siddiq M, Martinez J, Spencer T, Carmel J, Hart RB, et al: The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci. 26:5565–5573. 2006. View Article : Google Scholar : PubMed/NCBI
19	Siddiq MM and Hannila SS: Looking downstream: the role of cyclic AMP-regulated genes in axonal regeneration. Front Mol Neurosci. 8:262015. View Article : Google Scholar : PubMed/NCBI
20	Hannila SS and Filbin MT: The role of cyclic AMP signaling in promoting axonal regeneration after spinal cord injury. Exp Neurol. 209:321–332. 2008. View Article : Google Scholar
21	Lau BY, Fogerson SM, Walsh RB and Morgan JR: Cyclic AMP promotes axon regeneration, lesion repair and neuronal survival in lampreys after spinal cord injury. Exp Neurol. 250:31–42. 2013. View Article : Google Scholar : PubMed/NCBI
22	Peace AG and Shewan DA: New perspectives in cyclic AMP-mediated axon growth and guidance: the emerging epoch of Epac. Brain Res Bull. 84:280–288. 2011. View Article : Google Scholar
23	Schumann G, Huell M, Machein U, Hocke G and Fiebich BL: Interleukin-6 activates signal transducer and activator of transcription and mitogen-activated protein kinase signal transduction pathways and induces de novo protein synthesis in human neuronal cells. J Neurochem. 73:2009–2017. 1999.PubMed/NCBI
24	Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G, Valerio A and Spano P: Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci. 25:301–311. 2004. View Article : Google Scholar : PubMed/NCBI
25	Agthong S, Koonam J, Kaewsema A and Chentanez V: Inhibition of MAPK ERK impairs axonal regeneration without an effect on neuronal loss after nerve injury. Neurol Res. 31:1068–1074. 2009. View Article : Google Scholar : PubMed/NCBI
26	Liu RY and Snider WD: Different signaling pathways mediate regenerative versus developmental sensory axon growth. J Neurosci. 21:RC1642001.PubMed/NCBI
27	Wiklund P, Ekström PA and Edström A: Mitogen-activated protein kinase inhibition reveals differences in signalling pathways activated by neurotrophin-3 and other growth-stimulating conditions of adult mouse dorsal root ganglia neurons. J Neurosci Res. 67:62–68. 2002. View Article : Google Scholar
28	Teng FY and Tang BL: Axonal regeneration in adult CNS neurons - signaling molecules and pathways. J Neurochem. 96:1501–1508. 2006. View Article : Google Scholar : PubMed/NCBI
29	Hellenbrand DJ, Kaeppler KE, Hwang E, Ehlers ME, Toigo RD, Giesler JD, Vassar-Olsen ER and Hanna A: Basic techniques for long distance axon tracing in the spinal cord. Microsc Res Tech. 76:1240–1249. 2013. View Article : Google Scholar : PubMed/NCBI
30	Grasselli G, Mandolesi G, Strata P and Cesare P: Impaired sprouting and axonal atrophy in cerebellar climbing fibres following in vivo silencing of the growth-associated protein GAP-43. PLoS One. 6:e207912011. View Article : Google Scholar : PubMed/NCBI
31	Yuan Q, Hu B, Su H, So KF, Lin Z and Wu W: GAP-43 expression correlates with spinal motoneuron regeneration following root avulsion. J Brachial Plex Peripher Nerve Inj. 4:182009.PubMed/NCBI
32	Strittmatter SM: GAP-43 as a modulator of G protein transduction in the growth cone. Perspect Dev Neurobiol. 1:13–19. 1992.PubMed/NCBI
33	Fenrich KK, Skelton N, MacDermid VE, Meehan CF, Armstrong S, Neuber-Hess MS and Rose PK: Axonal regeneration and development of de novo axons from distal dendrites of adult feline commissural interneurons after a proximal axotomy. J Comp Neurol. 502:1079–1097. 2007. View Article : Google Scholar : PubMed/NCBI
34	Denny JB: Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43. Curr Neuropharmacol. 4:293–304. 2006. View Article : Google Scholar
35	Huo Y, Yin XL, Ji SX, Zou H, Lang M, Zheng Z, Cai XF, Liu W, Chen CL, Zhou YG, et al: Amino-Nogo inhibits optic nerve regeneration and functional recovery via the integrin αv signaling pathway in rats. Cell Physiol Biochem. 35:616–626. 2015. View Article : Google Scholar
36	Schwab ME and Strittmatter SM: Nogo limits neural plasticity and recovery from injury. Curr Opin Neurobiol. 27:53–60. 2014. View Article : Google Scholar : PubMed/NCBI
37	Kempf A and Schwab ME: Nogo-A represses anatomical and synaptic plasticity in the central nervous system. Physiology (Bethesda). 28:151–163. 2013. View Article : Google Scholar
38	Wälchli T, Pernet V, Weinmann O, Shiu JY, Guzik-Kornacka A, Decrey G, Yüksel D, Schneider H, Vogel J, Ingber DE, et al: Nogo-A is a negative regulator of CNS angiogenesis. Proc Natl Acad Sci USA. 110:E1943–E1952. 2013. View Article : Google Scholar : PubMed/NCBI
39	Ahmed Z, Dent RG, Suggate EL, Barrett LB, Seabright RJ, Berry M and Logan A: Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75^NTR and Rho-A. Mol Cell Neurosci. 28:509–523. 2005. View Article : Google Scholar : PubMed/NCBI
40	Wang T, Wang J, Yin C, Liu R, Zhang JH and Qin X: Down-regulation of Nogo receptor promotes functional recovery by enhancing axonal connectivity after experimental stroke in rats. Brain Res. 1360:147–158. 2010. View Article : Google Scholar : PubMed/NCBI